On January 31, 2023 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported that it will webcast management participation as follows (Press release, Regeneron, JAN 31, 2023, View Source [SID1234626666]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Securities Global Biopharma Conference at 9:20 a.m. ET on Tuesday,
February 14, 2023

Cowen 43rd Annual Health Care Conference at 12:50 p.m. ET on Monday,
March 6, 2023

Oppenheimer 33rd Annual Healthcare Conference at 9:20 a.m. ET on Monday,
March 13, 2023

Barclays Global Healthcare Conference at 9:00 a.m. ET on Wednesday,
March 15, 2023
The sessions may be accessed from the "Investors & Media" page of Regeneron’s website at View Source Replays of the webcasts will be archived on the Company’s website for at least 30 days.